NCT02419963 - Analyzing IBS to Identify Biomarkers and Microbiome Signatures | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 12, 2016

Study Completion Date

December 12, 2016

Conditions

Diarrhoea Predominant Irritable Bowel SyndromeIBS

Interventions

PROCEDURE

endoscopy for tissue biopsy

endoscopy to obtain tissue biopsy for analysis of biomarker status

OTHER

Blood Sample

Blood draw to evaluate serotonin and Vit D level.

OTHER

Stool Sample

Stool sample to evaluate microbiome fingerprint.

Trial Locations (1)

Mayo Clinic in Arizona, Scottsdale